Avaxim

Avaxim is a vaccine designed to protect against hepatitis A, a viral infection affecting the liver. It contains inactivated hepatitis A virus and is administered via intramuscular or subcutaneous routes.

Avaxim is primarily used for the prevention of hepatitis A, a contagious liver disease caused by the hepatitis A virus. This vaccine is often recommended for individuals traveling to regions with high rates of hepatitis A, as well as for those who may be at increased risk of infection due to their lifestyle or occupation. The vaccine works by stimulating the body's immune system to produce antibodies against the virus, providing long-term protection.

Common effects of Avaxim may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience mild fever, headache, or fatigue following vaccination. These effects are generally mild and short-lived, resolving within a few days.

Avaxim should be administered under the supervision of a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform your healthcare provider about any medical conditions or allergies before receiving the vaccine.

Avaxim may interact with certain medications or other vaccines. It is advisable to discuss your current medications and vaccination schedule with a healthcare professional before receiving Avaxim. Additionally, individuals with weakened immune systems should consult their healthcare provider regarding the appropriate timing and dosage of the vaccine.